🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 5 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/01/1996 | 30,36 | 31,01 | 30,30 | 30,89 | +1,77% | 2,36% | 5.094.957 |
| 15/01/1996 | 29,76 | 30,42 | 29,76 | 30,36 | +2,41% | 2,20% | 4.254.461 |
| 12/01/1996 | 29,46 | 29,88 | 29,28 | 29,64 | +1,02% | 2,02% | 5.035.011 |
| 11/01/1996 | 29,34 | 29,64 | 29,10 | 29,34 | +0,41% | 1,83% | 5.905.270 |
| 10/01/1996 | 30,06 | 30,12 | 29,10 | 29,22 | -3,54% | 3,37% | 6.985.339 |
| 09/01/1996 | 30,47 | 30,77 | 30,18 | 30,30 | -0,59% | 1,96% | 6.338.514 |
| 08/01/1996 | 30,06 | 30,53 | 30,00 | 30,47 | +1,39% | 1,79% | 1.786.840 |
| 05/01/1996 | 30,30 | 30,42 | 29,94 | 30,06 | -1,18% | 1,57% | 3.746.600 |
| 04/01/1996 | 30,18 | 30,59 | 29,94 | 30,42 | +0,59% | 2,17% | 7.501.794 |
| 03/01/1996 | 30,65 | 30,71 | 30,12 | 30,24 | -1,36% | 1,95% | 6.750.797 |
| 02/01/1996 | 30,89 | 31,01 | 30,59 | 30,65 | -2,10% | 1,35% | 6.354.234 |
| 29/12/1995 | 31,43 | 31,61 | 31,19 | 31,31 | -0,76% | 1,33% | 3.988.478 |
| 28/12/1995 | 30,89 | 31,73 | 30,89 | 31,55 | +1,93% | 2,70% | 5.047.378 |
| 27/12/1995 | 31,85 | 31,91 | 30,95 | 30,95 | -2,63% | 3,00% | 3.380.638 |
| 26/12/1995 | 31,13 | 31,91 | 30,83 | 31,79 | +2,50% | 3,45% | 3.985.125 |
| 22/12/1995 | 30,95 | 31,07 | 30,65 | 31,01 | +0,00% | 1,35% | 3.952.427 |
| 21/12/1995 | 30,12 | 31,07 | 30,00 | 31,01 | +2,97% | 3,56% | 7.729.629 |
| 20/12/1995 | 30,24 | 30,59 | 30,12 | 30,12 | -0,79% | 1,58% | 6.037.738 |
| 19/12/1995 | 30,83 | 30,95 | 30,06 | 30,36 | -1,93% | 2,90% | 7.648.723 |
| 18/12/1995 | 31,01 | 31,13 | 30,77 | 30,95 | -1,33% | 1,15% | 4.659.408 |
| 15/12/1995 | 31,91 | 31,91 | 31,25 | 31,37 | -1,68% | 2,06% | 11.125.778 |
| 14/12/1995 | 31,07 | 32,08 | 31,07 | 31,91 | +2,69% | 3,26% | 7.791.251 |
| 13/12/1995 | 30,42 | 31,19 | 30,36 | 31,07 | +2,96% | 2,75% | 7.081.546 |
| 12/12/1995 | 30,06 | 30,42 | 30,06 | 30,18 | +0,00% | 1,19% | 3.901.914 |
| 11/12/1995 | 30,12 | 30,30 | 30,00 | 30,18 | -0,39% | 0,99% | 3.881.163 |
| 08/12/1995 | 30,36 | 30,65 | 30,18 | 30,30 | +0,20% | 1,57% | 3.937.336 |
| 07/12/1995 | 30,30 | 30,77 | 30,24 | 30,24 | -0,59% | 1,77% | 5.123.253 |
| 06/12/1995 | 30,24 | 30,42 | 30,18 | 30,42 | +0,59% | 0,79% | 5.680.160 |
| 05/12/1995 | 29,58 | 30,36 | 29,52 | 30,24 | +2,22% | 2,82% | 6.809.066 |
| 04/12/1995 | 29,34 | 29,64 | 29,22 | 29,58 | +0,61% | 1,42% | 4.600.510 |